Purchase Order 75N90025P00539
Award Date
6/25/25
Potential Completion Date
7/24/25
Potential Value
$53K
Federal Agency
NIH Clinical Center
Awardee
10X Genomics, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94588, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to 10X Genomics, Inc., a biotechnology company in Pleasanton, California, is for the provision of reagents for microbiome research experiments. The contract has a ceiling value of $12,298.50 and is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency. The contract does not have a set-aside designation and runs through October 18, 2025. 10X Genomics is a leading provider of advanced genomic analysis...
This firm fixed-price purchase order contract, valued at $56,335.89, was awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms, reagents, and bioinformatics software. The contract is to provide reagents needed for ongoing research by the Critical Care Medicine Department at the NIH. This contract is not set aside and is part of a larger indefinite delivery contract (IDC) valued up to $7,000,000...
This is a firm fixed-price contract awarded by the National Institutes of Health (NIH) to 10X Genomics, Inc., a biotechnology company based in Pleasanton, California. The contract is for the supply of reagents needed for ongoing critical care medicine research in the NIH Clinical Center. The contract has a ceiling value of $24,969.50 and a period of performance ending on June 27, 2025. The contract is a Blanket Purchase Agreement (BPA) call, which is a type of indefinite delivery contract. 10X...
This is a federal contract award to 10X Genomics, Inc., a biotechnology company in Pleasanton, California, for the procurement of laboratory supplies. The contract has a ceiling value of $34,810.59 and a performance period ending on September 11, 2026. The contract is a purchase order with a firm fixed-price pricing type, awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency. The contract does not have a set-aside designation. 10X Genomics is the prime...
This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc., a biotechnology company that specializes in advanced genomic analysis platforms, reagents, instruments, and bioinformatics software. The contract, valued at $24,608.17, is for the delivery of 10X Genomics Kits to support biomedical research at the NIH. The contract does not have a set-aside designation. 10X Genomics has been awarded numerous federal...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc. for the supply of 10X Genomics reagents. The contract has a ceiling value of $42,000.00 and a period of performance through September 30, 2024. 10X Genomics, a for-profit manufacturer, is the prime contractor and no set-aside designation was used. The contract supports the NIH's research efforts, specifically in the area of neurological diseases and disorders. The...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to 10X Genomics, Inc. The contract has a ceiling value of $45,072.00 and is for the delivery of reagents to support ongoing clinical trials that began before January 20, 2025. The contract is not set aside and runs through June 30, 2025. 10X Genomics is a life sciences technology company that specializes in...
This is a $12,000 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc., a life sciences technology company headquartered in Pleasanton, California. The contract is not set aside and runs through July 2026. 10X Genomics will provide specialized scientific equipment, consumables, and research tools to support advanced biomedical research across various domains, including infectious diseases, cancer, neurological disorders, and...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc., a biotechnology company specializing in advanced genomic analysis platforms and reagents. The $22,333.75 contract is for the provision of reagents needed for research by the NIH's Critical Care Medicine Department, with an ultimate completion date of September 30, 2022. 10X Genomics, which is not a small business, has been awarded multiple...
This is a $29,079.50 firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms and reagents. The contract is for the provision of reagents needed for ongoing research by the NIH Critical Care Medicine Department. There is no set-aside designation for this contract. The award is not associated with a larger contract vehicle, but 10X Genomics has been awarded...